Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Revenue (2022 - 2025)

Historic Revenue for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to $2855.0.

  • Cardio Diagnostics Holdings' Revenue fell 5661.09% to $2855.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15782.0, marking a year-over-year decrease of 5577.79%. This contributed to the annual value of $34890.0 for FY2024, which is 10445.36% up from last year.
  • As of Q3 2025, Cardio Diagnostics Holdings' Revenue stood at $2855.0, which was down 5661.09% from $7475.0 recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Revenue ranged from a high of $15928.0 in Q1 2024 and a low of $940.0 during Q1 2025
  • Moreover, its 4-year median value for Revenue was $5310.0 (2023), whereas its average is $5834.1.
  • In the last 5 years, Cardio Diagnostics Holdings' Revenue surged by 45894.74% in 2023 and then plummeted by 9409.84% in 2025.
  • Cardio Diagnostics Holdings' Revenue (Quarter) stood at $950.0 in 2022, then soared by 458.95% to $5310.0 in 2023, then dropped by 15.03% to $4512.0 in 2024, then crashed by 36.72% to $2855.0 in 2025.
  • Its last three reported values are $2855.0 in Q3 2025, $7475.0 for Q2 2025, and $940.0 during Q1 2025.